Alpha Paradigm Partners, LLC Cerus Corp Transaction History

Alpha Paradigm Partners, LLC

  • $239 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $209,929 - $278,850
-35,164 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$4.79 - $6.68 $587,598 - $819,448
-122,672 Reduced 77.72%
35,164 $214 Million
Q2 2021

Aug 13, 2021
BUY
$5.35 - $6.35 $72,128 - $85,610
13,482 Added 9.34%
157,836 $933 Million
Q1 2021

May 14, 2021
BUY
$5.68 - $7.87 $819,930 - $1.14 Million
144,354 New
144,354 $867,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email